Japan Nobel winner vows to continue research to 'save more patients than ever'

October 1, 2018
Credit: CC0 Public Domain

The Japanese scientist who Monday won the Nobel Prize for medicine vowed to continue his cancer treatment work to help as many sufferers as possible, saying treating patients gave him more pleasure than any award.

"I want to continue my research ... so that this immune therapy will save more cancer patients than ever," Tasuku Honjo told reporters at Kyoto University where he is based.

He described his feelings of "immense joy" when people told him they had recovered from severe illnesses due to his work.

He said a member of his golf club, whom he did not know well, came up to him one day and thanked him, saying: "Thanks to your medicine. I had lung cancer and I thought I was playing my last round of golf, but now I am able to play golf again."

"When you hear things like that, there is no greater happiness. I have never been happier than that. Honestly, no award can replace that. I felt it was enough," said Honjo.

"On top of that, I am receiving such an award. I really feel I am a fortunate person."

Honjo said he heard the news of his award while he was discussing academic papers with colleagues and it came "completely out of the blue."

"Of course, I was very happy, delighted at the same time, but shocked."

During the press conference, Honjo took a call from Prime Minister Shinzo Abe, who congratulated the scientist, saying he was "so proud as a fellow Japanese."

Abe said someone he knew was saved by treatment resulting from the professor's research.

"The professor's achievement has given rays of hope to many cancer patients," said Abe.

Honjo won the prize, along with US scientist James Allison, for research into how the body's natural defences can fight cancer.

But he said he also has ambitions to go round the golf course in the same number of shots at his age.

"I am 76 now. My biggest goal is to hit 76 in golf."

Explore further: US, Japan duo win Nobel Medicine Prize for cancer therapy

Related Stories

US, Japan duo win Nobel Medicine Prize for cancer therapy

October 1, 2018
Two immunologists, James Allison of the US and Tasuku Honjo of Japan, won the 2018 Nobel Medicine Prize for research into how the body's natural defences can fight cancer, the jury said on Monday.

US, Japanese immunologists awarded Tang Prize for cancer quest

June 19, 2014
An American and a Japanese immunologist were Thursday named joint recipients of the Tang Prize, touted as Asia's version of the Nobels, for their contributions in the fight against cancer.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

Modest Nobel laureate says Japan deserves his prize

October 8, 2012
Japanese stem cell pioneer Shinya Yamanaka responded modestly after winning the Nobel prize for medicine Monday, saying his country really deserves the award.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.